Will be Updated soon..

Gurpreet Singh is currently the Vice President, Managing Director Integrated Safety at IQVIA. He is based in UK and has a total of 20 years' experience in Pharma Industry of which 18+ years have been in Global Drug Development. During these years he has had the opportunity to work with some top Global companies like Cognizant, Tata Consultancy, Novartis and Parexel. At Novartis he was the Global Head of PV Operations managing all Global PV activities. At Parexel he was the Senior Director PV Operations responsible for managing PV projects of top Global Pharma and Biotech companies. Gurpreet is a certified Six Sigma and Project Management Professional. He has keen interest in Digital Transformation and Organization Culture and has successfully led various projects during his tenure in the Pharma Industry. He is an avid runner and a speaker at various Pharma conferences.

Dr. Michael Aschner is a distinguished scientist and professor with expertise in molecular pharmacology, neuroscience, and pediatrics. He holds the prestigious Harold & Muriel Block Chair in Molecular Pharmacology and serves as the Director of the Einstein Center of Toxicology. Dr. Michael Aschner ’s research focuses on the mechanisms underlying mercury- and manganese-induced neurotoxicity, with a particular emphasis on genetic factors influencing susceptibility to these toxicants. His work explores the role of dopamine signaling in the progression of dopaminergic neurodegeneration, shedding light on the biological pathways that contribute to neurodegenerative disorders. Additionally, he investigates the impact of metal exposure on conditions such as restless legs syndrome, contributing to the broader field of neurotoxicology. With an extensive background in molecular and neuropharmacology, Dr. Michael Aschner has made significant contributions to understanding the intersection of environmental toxicants and neurological health. His research has been widely recognized in the scientific community, and he continues to lead innovative studies aimed at advancing therapeutic strategies for metal-induced neurotoxicity.

Prof. Heba Shahatou is a distinguished professor in the Faculty of Medicine with over a decade of experience in teaching, research, and clinical practice. With expertise in clinical medicine and healthcare innovation, they have successfully integrated academic instruction with practical medical applications, fostering a comprehensive learning environment for students and professionals alike. Throughout their career, they have contributed extensively to peer-reviewed publications and have been recognized with prestigious awards for their dedication to medical education and mentorship. Their active involvement in interdisciplinary collaborations has enriched their perspective on contemporary healthcare challenges, enabling them to drive advancements in the field while guiding the next generation of medical professionals toward excellence.

Neha Mehta is a seasoned Regulatory CMC Facilitator at Novartis, specializing in the technical transfer and launch of pharmaceutical products. She plays a pivotal role in ensuring audit compliance, managing regulatory queries, and overseeing change control activities within AGILE. Neha possesses a robust technical background in regulatory affairs, quality management, analytical sciences, and project management. She holds esteemed professional certifications, including PMP, RAC (US & EU), and PRINCE2 Agile Practitioner, reflecting her expertise in regulatory strategy and operational excellence. Her extensive experience spans the entire product lifecycle, from pre- to post-approval stages, with a focus on global regulatory submissions across diverse therapeutic areas such as Oncology, Pediatrics, Dermatology, Cardiovascular, Diabetes, and Antibiotics. She has successfully led regulatory strategies for key markets, including EMEA, TGA, Health Canada, Japan, and the FDA. In addition to her regulatory expertise, Neha has conducted data integrity audits in both R&D and manufacturing settings and has contributed to the harmonization and review of analytical validations. She excels in cross-functional collaboration, customer engagement, and delivering strategic solutions with an entrepreneurial mindset, customer-centric approach, and strong team leadership.

Venko Georgiev serves as Chief Expert in the Toxicology Department at the National Center of Public Health and Analyses (NCPHA), Bulgaria. With extensive expertise in public health, environmental toxicology, and chemical safety, he plays a vital role in assessing and managing toxicological risks to public health. Mr. Georgiev’s work focuses on toxicological evaluations, risk assessments of chemical substances, and developing policies and guidelines to enhance health protection and safety standards in Bulgaria. His contributions are instrumental in supporting national health strategies and ensuring compliance with European and international health regulations.

Will be updated soon...

Lyudmyla Symochko got her Master’s degree in Ecology and Environment Protection in 2000. Doctor’s degree (Ph.D.) by Specialty – 03.00.16 Ecology in 2005. She is Associate Professor since 2008. Professional Career: Prof. Assoc., Dr., a lecturer at the Faculty of Biology, Uzhhorod National University, Ukraine. Symochko Lyudmyla – a specialist in environmental microbiology and ecology. Since 2008 she has focused on autecology and synecology researches of soil and water microbiota. Explores the soil resistome and the role of natural and transformed ecosystems as a reservoir of antibiotic-resistant microorganisms. She is developing new and improving existing methods of bioindication and bioremediation. Helds microbiological monitoring in different types of ecosystems. Detects antibiotic-resistant opportunistic pathogens in the environment and provide they risk assessment to human health. Author of over 150 scientific publications, including 5 books. Participant and co-organizer of numerous international congresses and conferences. Member of the editorial board of 9 International scientific journals.

Dr. Rajendra Singh is experienced toxicology and biocompatibility expert with a strong background in safety assessment of chemicals in medical devices, cosmetics, healthcare, and consumer products. Skilled in regulatory submissions to the FDA and global agencies for various medical devices, including implantable, surgical, and combination drug/device products. Proficient in ISO 10993 and ISO 18562 standards, toxicological risk assessments, and regulatory compliance strategies for EU MDR. Expertise in chemical characterization, alternative toxicology methods, computational modeling, and reducing regulatory review times. Extensive experience in study design, technical writing, and scientific communication through peer-reviewed publications and presentations.

Will be Updated soon..

Will be Updated soon..

Dr. Nassim Macher is an Anthropology - Clinical And Forensic Medicine - Crimalistics - Criminology - Odontology - Radiology And Imaging - Toxicology